NCCN Patient Webinar: Advanced and Metastatic Bladder Cancer

Experts discuss understanding advanced and metastatic bladder cancer and its various treatment options, how to engage in shared decision-making, clinical trials, getting a second opinion, and tips for navigating patient and caregiver resources.

Topics Discussed
00:00 Welcome
01:59 Introduction and NCCN Guidelines® for Bladder Cancer
04:02 Urothelial carcinoma
04:36 Incidence and mortality
07:15 Staging
09:53 Common symptoms and risk factors
11:48 Diagnostic evaluation and office cystoscopy
12:46 Papillary tumor
13:58 Patient counseling
14:53 Transurethral resection
15:58 Intravesical therapy
16:46 Radical cystoprostatectomy
18:24 Nerve-sparing cystectomy and organ-sparing cystectomy
20:07 Pelvic lymph node dissection
20:39 Outcomes after cystectomy
21:10 Neoadjuvant chemotherapy
22:02 Urinary diversion, neobladder, and continent cutaneous diversion
24:10 Importance of multidisciplinary care
24:48 Systemic therapy
27:17 Preoperative (neoadjuvant) chemotherapy
28:54 Comparing outcomes with chemotherapy regimens
31:23 Upper tract urothelial carcinoma
32:15 Postoperative (adjuvant) chemotherapy
33:51 Comparing postoperative chemotherapy versus placebo
35:22 Therapy for recurrent and metastatic cancer
37:50 Overview of FDA approved agents
42:55 Evolving standard of care and emerging data
46:37 Cost of care and review
49:20 Helpful resources, including NCCN Guidelines for Patients®
54:19 Bladder Cancer Advocacy Network (BCAN)
59:02 World Bladder Cancer Patient Coalition
59:54 Finding clinical trials
1:02:07 Guidance from bladder cancer survivor

Q&A Session
1:06:06 Can you speak more about side effects of TURBT (transurethral resection of bladder tumor) and paralysis?
1:08:09 What is the age of people having procedures and life expectancy after some of the procedures?
1:09:56 Is chemo the first line of therapy rather than surgery?
1:11:52 Who else can help make treatment decisions and how long does a patient have to make a decision?
1:15:39 Why can’t urine be diverted to the rectum after the bladder is removed?
1:17:03 If you receive neoadjuvant chemo and then your bladder cancer recurs do you use the same agent? How are those decisions made?
1:18:50 Can you provide clarity about the price of treatment?
1:20:55 Where can people seek assistance for paying for treatment?


The Patient Webinar on Advanced and Metastatic Bladder Cancer occurred in February 2024. This program was created in conjunction with the NCCN Guidelines for Patients® for Bladder Cancer: https://www.nccn.org/patientresources...

The NCCN Guidelines for Patients are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.
NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.

Supporters:
This webinar is supported through the NCCN Foundation and by contributions from our corporate supporter: EMD Serono, Inc.

__________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit http://www.nccn.org/patients/foundation
__________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.

Subscribe to our channel: https://www.youtube.com/c/NCCNvideo?s...

Connect with us!
X:   / nccn  
LinkedIn:   / nccn  
Facebook:   / nccnorg  
Instagram:   / nccnorg